Article citationsMore>>

C. Avgeropoulou, I. Andreadou, S. Markantonis-Ky- roudis, M. Demopoulou, P Missovoulos, A. Androulakis and I. Kallikazaros, “The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine,” Eur J Heart Fail, Vol. 7, No. 5, 2005, pp. 882-887.

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top